Beximco Pharmaceuticals Ltd.
Manufacturer of generic drugs, APIs, and specialized products for global markets.
BXP | IL
Overview
Corporate Details
- ISIN(s):
- US0885792061
- LEI:
- 213800IMBBD6TIOQGB56
- Country:
- Bangladesh
- Address:
- N/A
- Website:
- https://www.beximcopharma.com
- Sector:
- Manufacturing
Description
Beximco Pharmaceuticals Ltd. is a manufacturer of generic drugs and active pharmaceutical ingredients (APIs). The company produces a broad portfolio of over 500 products across various therapeutic categories, with a focus on providing access to affordable medicines. It has established a strong market differentiation through a range of high-tech, specialized products, including metered-dose and dry powder inhalers. Serving numerous emerging and developed markets globally, its manufacturing facilities are accredited by major international regulatory authorities, including those of the USA, European Union, Australia, and Canada.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-23 08:00 |
Annual General Meeting Statement
|
English | HTML • 11.7 KB | ||
| 2022-11-29 15:06 |
Second Price Monitoring Extn
|
English | HTML • 3.0 KB | ||
| 2022-11-29 15:00 |
Price Monitoring Extension
|
English | HTML • 3.0 KB | ||
| 2022-11-16 08:00 |
AGM Notification
|
English | HTML • 17.8 KB | ||
| 2022-11-11 08:00 |
Financial Results for the First Quarter
|
English | HTML • 226.9 KB | ||
| 2022-11-08 08:00 |
Results for the 12-month period ended 30 June 2022
|
English | HTML • 170.3 KB | ||
| 2022-10-28 08:00 |
Notification of Preliminary Results and AGM
|
English | HTML • 24.5 KB | ||
| 2022-04-28 08:00 |
Q3 Financial Results
|
English | HTML • 283.2 KB | ||
| 2022-04-01 08:00 |
Sanofi Bangladesh Ltd. renamed Synovia Pharma PLC
|
English | HTML • 11.0 KB | ||
| 2022-03-17 15:30 |
MPP sub-license for Pfizer’s COVID-19 treatment
|
English | HTML • 13.7 KB | ||
| 2022-01-28 08:00 |
Half Year Results 2021-22
|
English | HTML • 159.0 KB | ||
| 2022-01-21 08:00 |
Payment of Cash Dividend
|
English | HTML • 10.8 KB | ||
| 2022-01-20 10:00 |
License to produce molnupiravir for COVID-19
|
English | HTML • 13.0 KB | ||
| 2021-12-30 11:38 |
World's first generic version of Pfizer’s Paxlovid
|
English | HTML • 13.3 KB | ||
| 2021-12-24 08:00 |
Annual General Meeting Statement
|
English | HTML • 10.9 KB |
Automate Your Workflow. Get a real-time feed of all Beximco Pharmaceuticals Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Beximco Pharmaceuticals Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Beximco Pharmaceuticals Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
